Llama antibodies blunt Covid in lab trial, says Belgian start-up

Llama antibodies could soon be playing a role in the global fight against Covid-19, if clinical trials being conducted by a Belgian biomedical start-up live up to their early promise.

Researchers from the VIB-UGent Center for Medical Biotechnology in Ghent say antibodies extracted from a llama called Winter have blunted the virulence of coronavirus infections, including variants, in...